Beta-blockers and spironolactone in heart failure Marrick L. Kukin Clinical Trials Review Pages: 87 - 89
The effects of neurohormonal antagonism on pathologic left ventricular remodeling in heart failure William L. LombardiEdward M. Gilbert OriginalPaper Pages: 90 - 98
Surgical approaches to dilated cardiomyopathy Iva A. SmolensSteven F. Bolling OriginalPaper Pages: 99 - 105
Cardiomyopathy and embolization: risks and benefits of anticoagulation in sinus rhythm Robert RhoDavid DeNofrioEvan Loh OriginalPaper Pages: 106 - 111
The myocardial matrix and the development and progression of ventricular remodeling Jonathan D. Sackner-Bernstein OriginalPaper Pages: 112 - 119
Insights into pathogenesis and treatment of cytokines in cardiomyopathy Lou VadlamaniWilliam T. Abraham OriginalPaper Pages: 120 - 128
Analysis of dual-chamber pacing as a treatment for refractory limiting symptoms in patients with obstructive hypertrophic cardiomyopathy Barry J. Maron Clinical Trials Review Pages: 131 - 133
Medical treatment of hypertrophic cardiomyopathy Mark V. SherridDavid GunsburgAjay Sharma OriginalPaper Pages: 148 - 153
Percutaneous transluminal septal myocardial ablation David N. RubinE. Murat TuzcuHarry M. Lever OriginalPaper Pages: 160 - 165